BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 18713984)

  • 21. Suppression of allergic inflammation by allergen-DNA-modified dendritic cells depends on the induction of Foxp3+ Regulatory T cells.
    Wu K; Bi Y; Sun K; Xia J; Wang Y; Wang C
    Scand J Immunol; 2008 Feb; 67(2):140-51. PubMed ID: 18201369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
    Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70.
    Pen JJ; De Keersmaecker B; Maenhout SK; Van Nuffel AM; Heirman C; Corthals J; Escors D; Bonehill A; Thielemans K; Breckpot K; Aerts JL
    J Immunol; 2013 Aug; 191(4):1976-83. PubMed ID: 23842750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammation.
    Heckman KL; Radhakrishnan S; Peikert T; Iijima K; McGregor HC; Bell MP; Kita H; Pease LR
    Eur J Immunol; 2008 Sep; 38(9):2464-74. PubMed ID: 18819071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells.
    Lau AW; Biester S; Cornall RJ; Forrester JV
    J Immunol; 2008 Mar; 180(6):3889-99. PubMed ID: 18322197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
    Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
    Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes.
    Turner MS; Isse K; Fischer DK; Turnquist HR; Morel PA
    Diabetologia; 2014 Jul; 57(7):1428-36. PubMed ID: 24737163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells.
    Li X; Yang A; Huang H; Zhang X; Town J; Davis B; Cockcroft DW; Gordon JR
    Am J Respir Cell Mol Biol; 2010 Feb; 42(2):190-9. PubMed ID: 19372244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-driven interactions with dendritic cells and expansion of Foxp3+ regulatory T cells occur in the absence of inflammatory signals.
    Chappert P; Leboeuf M; Rameau P; Stockholm D; Liblau R; Danos O; Davoust JM; Gross DA
    J Immunol; 2008 Jan; 180(1):327-34. PubMed ID: 18097034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells.
    Benkhoucha M; Santiago-Raber ML; Schneiter G; Chofflon M; Funakoshi H; Nakamura T; Lalive PH
    Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6424-9. PubMed ID: 20332205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells.
    Matsumura Y; Kobayashi T; Ichiyama K; Yoshida R; Hashimoto M; Takimoto T; Tanaka K; Chinen T; Shichita T; Wyss-Coray T; Sato K; Yoshimura A
    J Immunol; 2007 Aug; 179(4):2170-9. PubMed ID: 17675476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
    Lo J; Xia CQ; Peng R; Clare-Salzler MJ
    J Immunol Res; 2018; 2018():5463879. PubMed ID: 29651443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity.
    Tarbell KV; Yamazaki S; Steinman RM
    Semin Immunol; 2006 Apr; 18(2):93-102. PubMed ID: 16469503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity.
    Carrier Y; Yuan J; Kuchroo VK; Weiner HL
    J Immunol; 2007 Jan; 178(1):172-8. PubMed ID: 17182552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-derived CD4+CD25+ Tregs inhibit the maturation and antigen-presenting function of dendritic cells.
    Du Y; Chen X; Lin XQ; Wu W; Huang ZM
    Asian Pac J Cancer Prev; 2015; 16(7):2665-9. PubMed ID: 25854343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.